9PVH | pdb_00009pvh

Human Cullin-4 in complex with CAND2

  • Classification: LIGASE
  • Organism(s): Homo sapiens
  • Expression System: Escherichia coli
  • Mutation(s): No 

  • Deposited: 2025-08-01 Released: 2026-06-10 
  • Deposition Author(s): Kenny, S., Liu, X., Das, C.
  • Funding Organization(s): National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)

Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 4.38 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Starting Model: in silico
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9PVH

This is version 1.0 of the entry. See complete history

Literature

CAND1 and CAND2 drive CUL4 substrate receptor exchange with largely comparable biochemical efficiency, unlike their relative effects on CUL1.

Wang, K.Kenny, S.Chagan, Z.Li, L.Das, C.Liu, X.

(2026) Structure 

  • DOI: https://doi.org/10.1016/j.str.2026.02.015
  • Primary Citation Related Structures: 
    9PVH

  • PubMed Abstract: 

    Cullin-RING ubiquitin ligases (CRLs) regulate diverse cellular processes by dynamically recruiting substrate receptors onto conserved cullin-RING scaffolds. CAND1 and CAND2 function as substrate receptor exchange factors for CRL1, but CAND2 displays reduced efficiency in CRL1 disassembly, exhibits tissue-specific expression, and shows distinct disease associations, raising questions about its function in other CRL subfamilies. Here, we define the regulatory roles of CAND1 and CAND2 in CRL4 remodeling. Using genetic perturbation, real-time kinetic analyses, and quantitative interaction proteomics, we show that both CAND proteins promote CRL4-mediated protein degradation and enhance the dynamic exchange of DDB1·DCAF substrate receptor modules, likely through conserved yet distinct structural features. In contrast to their differential efficiencies in CRL1 disassembly, CAND1 and CAND2 exhibit similar kinetic parameters and comparable exchange efficiencies across most of the CRL4 complexes. These findings establish CAND1 and CAND2 as bona fide CRL4 exchange factors and reveal biochemical distinctions between CRL4 and CRL1 regulation.


  • Organizational Affiliation
    • Department of Biochemistry, Purdue University, West Lafayette, IN 47907, USA.

Macromolecule Content 

  • Total Structure Weight: 221.26 kDa 
  • Atom Count: 14,580 
  • Modeled Residue Count: 1,862 
  • Deposited Residue Count: 1,973 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Cullin-4A726Homo sapiensMutation(s): 0 
Gene Names: CUL4A
UniProt & NIH Common Fund Data Resources
Find proteins for Q13619 (Homo sapiens)
Explore Q13619 
Go to UniProtKB:  Q13619
PHAROS:  Q13619
GTEx:  ENSG00000139842 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ13619
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Cullin-associated NEDD8-dissociated protein 2B [auth C]1,247Homo sapiensMutation(s): 0 
Gene Names: CAND2KIAA0667TIP120B
UniProt & NIH Common Fund Data Resources
Find proteins for O75155 (Homo sapiens)
Explore O75155 
Go to UniProtKB:  O75155
PHAROS:  O75155
GTEx:  ENSG00000144712 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO75155
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 4.38 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
MODEL REFINEMENTPHENIX1.19.2_4158
RECONSTRUCTIONcryoSPARC3.2.0

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR35GM138016

Revision History  (Full details and data files)

  • Version 1.0: 2026-06-10
    Type: Initial release